Revance Therapeutics | RVNC - Trade Creditors

Revance Therapeutics reported $4.55M in Trade Creditors for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Trade Creditors Change
Cara Therapeutics CARA:US USD 9.6M 5.61M
Coherus Biosciences CHRS:US USD 11.53M 1.61M
Endo International Ordinary Shares ENDP:US USD 85M 5.64M
Horizon Pharma HZNP:US USD 155.8M 123.69M
JAZZ PHA JAZZ:US USD 90.76M 11.49M
Pacira Pharmaceuticals PCRX:US USD 15.22M 2.29M
Procter & Gamble PG:US USD 14.15B 692M
Revance Therapeutics RVNC:US USD 4.55M 3.8M
Supernus Pharmaceuticals SUPN:US USD 10.54M 5.47M
Teva Pharmaceutical Industries TEVA:US USD 1.89B 252M